ASK PINNACLE · QUESTIONS, EXPLANATIONS & NEXT STEPS
Motor
Explore explanations, everyday questions and next steps connected with motor.
4,352 published answers · English · Page 62
CHOOSE THE QUESTION THAT MATTERS NOW
Explore this topic, one useful question at a time.
Causes & influences
The question links above are from this page. Topic groups can continue on later pages; the complete answer list and its pagination remain below.
Causes & influences
What causes toe-walking in a 1-year-old?
In most one-year-olds, toe-walking is a normal part of learning to walk and is commonly idiopathic, settling on its own. Occasionally it links to calf tightness, sensory preferences or tone differences. Persistent, one-sided or stiff toe-walking warrants a gentle developmental check — never self-diagnosed, only reviewed by a Pinnacle clinician.
Read the answer AnswerWhat causes toe-walking in a 2-year-old?
Toe-walking at 2 is most often idiopathic (habitual) and fades on its own, with a normal exam and supple calves. Check it when it's constant, one-sided, paired with tight calves or frequent falls, or alongside speech, social or sensory differences. Developmental measurement supports care planning; diagnosis requires an appropriately qualified healthcare professional. under qualified clinician care.
Read the answer AnswerWhat Causes Toe-Walking in a 3-Year-Old?
In a three-year-old, toe-walking is most often idiopathic — a habit a child grows out of — but it can also follow tight calf muscles, sensory preferences, or, less commonly, neuromuscular factors. It is usually harmless if the child can also walk flat-footed and is developing well; persistent, one-sided, or stiff toe-walking, or any loss of skills, deserves a developmental check at a Pinnacle centre.
Read the answer AnswerWhat Causes Toe-Walking in a 4-Year-Old?
Most toe-walking at four years is habitual (idiopathic) — the child can walk flat but prefers toes. It may also involve tight calf muscles, sensory preferences, or occasionally differences in tone or coordination. A check is wise if it's constant, heels won't reach the floor, or other milestones lag.
Read the answer AnswerWhat Causes Toe-Walking in a 5-Year-Old?
Toe-walking in a five-year-old is most often idiopathic (a learned habit) and harmless, but can also stem from a tight Achilles tendon, sensory differences, or less commonly neurological or developmental conditions. The key question is whether the child can flatten their heels and whether it's occasional or constant. Developmental measurement supports care planning; diagnosis requires an appropriately qualified healthcare professional.
Read the answer AnswerWhat causes toe-walking in young children?
Most toe-walking in young children is idiopathic (habitual) and resolves with age. Less commonly it stems from tight calf muscles, sensory preferences, or developmental differences. A friendly check is wise if a child toe-walks most of the time past age 2–3, can't get heels down, or has other developmental concerns.
Read the answer AnswerWhat causes Tourette Syndrome in young children?
Tourette Syndrome in young children is a neurodevelopmental condition with a strong genetic component, linked to differences in the brain's movement-regulating circuits and dopamine signalling. It is not caused by parenting, diet or stress — though stress and tiredness can make tics more visible. Diagnosis is established only by qualified clinicians.
Read the answer AnswerCost-effectiveness of early therapy for Cerebral Palsy in young children
Early therapy for Cerebral Palsy is highly cost-effective because the early-childhood brain is most adaptable, so each therapy hour yields larger, lasting functional gains. Timely intervention reduces lifelong dependency costs and prevents expensive secondary complications. The value case favours timely therapy over the compounding cost of delay.
Read the answer AnswerCost-effectiveness of early therapy for Developmental Coordination Disorder
Early, goal-directed therapy for Developmental Coordination Disorder (ICD-11 6A04) is regarded as cost-effective because it prevents downstream education, mental-health and participation costs that arise when motor difficulties persist unsupported. Brief, task-oriented models build family and classroom capability, extending each clinician hour and intercepting the secondary anxiety-and-avoidance cascade early. For payers, the meaningful comparison is structured early therapy versus predictable later remediation spend.
Read the answer AnswerCost-effectiveness of early therapy for Fine Motor Delay
Early therapy for Fine Motor Delay is highly cost-effective: small, well-timed inputs in the early years prevent costlier later interventions, protect school readiness and reduce caregiver and system burden. Outcome-tracked, clinician-governed episodes deliver better cost-per-outcome than delayed or open-ended care.
Read the answer AnswerCost-effectiveness of early therapy for Gross Motor Delay
Early therapy for gross motor delay is a high-return investment: intervening during peak neural plasticity reaches functional goals in fewer sessions and reduces downstream costs across health, education and disability support. Value is strongest when delay is screened early and tied to measured outcomes. A clinical AbilityScore is formed only at a Pinnacle centre under clinician care.
Read the answer AnswerCost-effectiveness of early therapy for hypotonia
Early therapy for hypotonia is highly cost-effective because the developing nervous system is most plastic in the first years, so the same intervention yields larger, more durable functional gains earlier than later. Timely physiotherapy and occupational therapy reduce reliance on prolonged higher-cost care and lower indirect family and system costs. The decisive variable is how early support begins, beginning always with clinician assessment.
Read the answer AnswerCost-effectiveness of early therapy for motor planning difficulties
Early therapy for motor planning difficulties is cost-effective because the young brain responds fastest, so fewer targeted sessions yield durable gains. Early investment displaces larger later spending on remediation, special-education support and lost participation. Outcome-linked, clinician-governed programmes let payers fund against measurable progress.
Read the answer AnswerCost-effectiveness of early therapy for persistent toe-walking
Early conservative therapy for persistent toe-walking is the cost-conscious choice: a short course of physiotherapy and home stretching costs far less than the downstream casting, orthoses, botulinum toxin or surgery a minority of untreated, fixed cases require. Investing early reduces the proportion who escalate, lowering both direct and indirect costs.
Read the answer AnswerCost-effectiveness of early therapy for Stereotyped Movement Disorder
Early therapy for stereotyped movement disorder (ICD-11 6A06) is highly cost-effective: it uses peak neuroplasticity to reach functional outcomes in fewer sessions and reduces costly downstream supports, especially for self-injurious stereotypies. For payers the meaningful metric is cost per functional outcome over time, anchored by a clinician-administered baseline.
Read the answer AnswerCost-effectiveness of early therapy for Tourette Syndrome in young children
Early behavioural therapy for Tourette Syndrome in young children — chiefly CBIT and habit-reversal — is highly cost-effective for payers because it is time-limited, skills-based and offsets the costlier downstream burden of unmanaged tics, comorbid anxiety and medication. Value is greatest when commissioned as a behaviour-first pathway with baseline-to-outcome measurement.
Read the answer AnswerCerebral Palsy in India: prevalence and public-health burden
Cerebral Palsy (ICD-11 8D20) is the commonest cause of childhood physical disability, with prevalence around 2–3 per 1,000 live births globally and comparable or higher figures in Indian community studies. Across India's large birth cohort this is a substantial burden, amplified by late identification, uneven early-intervention access, and co-occurring epilepsy, communication and feeding needs.
Read the answer AnswerPrevalence and public-health burden of DCD in India
Developmental Coordination Disorder (ICD-11 6A04) affects an estimated 5–6% of school-age children internationally, implying several million affected children in India — the great majority undiagnosed. India's burden is driven by under-recognition rather than rarity, making screening and referral pathways the key public-health priority.
Read the answer AnswerFine Motor Delay: Prevalence and Public-Health Burden in India
India lacks a single national prevalence figure for Fine Motor Delay in isolation; it sits within broader developmental-delay surveillance, where community studies range from a few percent to roughly one in ten. The burden is real but under-detected, and embedding low-cost fine-motor screening into existing ICDS and RBSK platforms is a high-return public-health strategy.
Read the answer AnswerGross Motor Delay in India: Prevalence & Public-Health Burden
India has no single national prevalence figure for gross motor delay in isolation; it forms a substantial share of overall developmental delay, observed in roughly 1 in 10 young children in community studies, concentrated where prematurity, low birth weight and undernutrition cluster. Its public-health value lies in being an early, visible, modifiable marker — best addressed through routine milestone surveillance and timely early intervention.
Read the answer AnswerHypotonia prevalence and public-health burden in India
There is no single validated national prevalence figure for hypotonia in young Indian children, because it is a clinical sign with many causes rather than one disease. It is, however, among the commonest motor presentations at early developmental assessment and a key gateway sign to treatable conditions — making early screening, referral and motor therapy its central public-health value.
Read the answer AnswerPrevalence and public-health burden of Motor Planning Difficulties in India
There is no validated India-specific prevalence figure for Motor Planning Difficulties; global estimates for Developmental Coordination Disorder sit around 5–6% of school-aged children. In India the public-health burden is driven less by raw prevalence than by late identification and high co-occurrence with speech, attention and sensory conditions. The priority for government partners is standardised screening and surveillance, not a single headline number.
Read the answer AnswerPersistent Toe-Walking: Prevalence and Public-Health Burden in India
India has no national prevalence registry for persistent toe-walking, so country-level figures are unreliable; international community studies place idiopathic toe-walking in the low single-digit percentages of young children. Most cases are benign and self-resolving — the real public-health burden lies in missed cases that develop calf and Achilles tightness, and in the small group signalling an underlying neuromuscular or developmental condition. Structured early screening within existing child-health checks is the highest-value response.
Read the answer AnswerPrevalence and public-health burden of Stereotyped Movement Disorder in young children in India
India has no robust single national prevalence figure for Stereotyped Movement Disorder (ICD-11 6A06) in young children; the condition is under-recognised because mild stereotypies are common. The actionable public-health priority is strengthening early identification within existing developmental screening, especially where stereotypies co-occur with autism or intellectual developmental conditions.
Read the answer